Making a Business Case for PAT and QbD ImplementationHosted By : Andrea Charles
October 31, 2011
Brett Cooper | Merck | PAT | QbD | quality by design | PAT and QbD implementation | FDA | EMEA | QbD principles | process analytical technology
About this Podcast...
What are the 7 Deadly Sins of Quality Assurance and Quality Control?
Download our free QA QC eBook now to find out!
In this presentation Brett Cooper Research Fellow, MSD Development Laboratories, speaks to Andrea Charles from Pharma IQ, about the slower than anticipated industry uptake of PAT and QbD, the key benefits of PAT and QbD implementation and the biggest challenge pharma and bio companies face regarding the interpretation of regulatory guidance. Cooper also discusses how to prove the business case for PAT and QbD implementation.
Have Your Say
Rate this feature and give us your feedback in the comments section below
to get access to this White Paper
comments powered by Disqus
11th Laboratory Informatics Summit
Wyndham Philadelphia Historic District, Philadelphia, PA
January 25- 27, 2016
Software for medical Devices Europe
Hilton Munich City , Munich, Germany
February 22- 24, 2016
Biosimilars Clinical Studies and Analytical Similarity
March 21- 23, 2016